South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
批准号:
10798895
负责人:
Kenneth D. Tew
金额:
$18.95万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-07-31
关键词:
AbbreviationsAccountabilityAchievementAdvisory CommitteesAnalytical BiochemistryAreaAutomobile DrivingAwardBioenergeticsBiologyBiomedical ResearchBiotechnologyCancer CenterCardiovascular DiseasesCellsCenters of Research ExcellenceCollaborationsComplementCore FacilityDiabetes MellitusDisciplineDiseaseDrug AddictionEconomicsEngineeringEquilibriumEquipmentExtramural ActivitiesFacultyFinancial SupportFosteringFundingGastrointestinal AgentsGastrointestinal DiseasesGoalsGrantGrowthHealthHomeostasisHumanHuman PathologyImageIndividualInfrastructureInstitutionInterdisciplinary StudyInterventionMalignant NeoplasmsMass Spectrum AnalysisMedicalMedicineMentorsMetabolic dysfunctionMissionModelingMolecularMusculoskeletalNational Institute of General Medical SciencesNeurodegenerative DisordersOrganismOxidantsOxidation-ReductionOxidative PhosphorylationOxidative StressOxygenPaperPathologicPathway interactionsPeer ReviewPhasePilot ProjectsPositioning AttributeProteomicsPublished CommentPublishingRecoveryResearchResearch InfrastructureResearch PersonnelResource SharingResourcesRoleScientific Advances and AccomplishmentsSecureServicesSignal TransductionSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSourceSouth CarolinaStressTalentsTeacher Professional DevelopmentTherapeuticTissuesToxic effectTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkforce Developmentbasecareercollaborative environmentcollegecommercial applicationcostdesignexperiencefaculty supporthuman diseaseimaging capabilitiesimprovedinfrastructure developmentmass spectrometric imagingmembermicroscopic imagingmulti-photonmultidisciplinarynew technologynoveloutreachprogramsrecruitsuccesstargeted treatmenttranslational goalultra high resolution
中文摘要
整体-摘要
在第三阶段Cobre的支持下,南卡罗来纳中心在氧化剂、氧化还原平衡和压力信号方面
(Redox Cobre)在南卡罗来纳医科大学(MUSC)将完成向长期
可持续发展是氧化还原病理生物学领域具有全国竞争力的多学科研究项目。在.期间
在第一阶段和第二阶段,我们的Redox Cobre成功地努力:(I)扩大资助的临界质量
MUSC的研究人员研究氧化还原途径和代谢功能障碍在多种疾病中的因果作用
人类病理学(癌症、心血管和神经退行性疾病、糖尿病、胃肠道疾病
(2)开发先进的科学核心资源,提供广泛的
研究氧化应激在生物学上的重大影响的能力。我们目前的核心会员
由44名高级和初级教员组成,自成立以来已获得超过5100万美元的奖励
项目的开始。到目前为止,Redox Cobre总共指导了20名目标教员(初级调查人员
试点项目支持的绩效指标)。在这些人中,有10人得到了提升,16人留在了我们的
机构。作为一个团队,这些教职员工发表了250多篇同行评议的论文,并获得了
56个校外补助金奖(包括31个NIH补助金(PI角色),其中16个是R01奖,8个是SBIR/STTR--
支持的初创企业)。这项第三阶段提案的主要组成部分是:(1)行政核心,提供
组织、协调、财政和问责职能;(2)分析性氧化还原核心交付
用于定量氧化还原敏感分子丰度和基于氧化还原的分析生化服务
细胞内稳态的变化;(3)提供最先进的质谱学(MS)和
MS成像能力;(4)细胞和分子氧化还原成像核心,提供基于细胞和组织的
共焦、多光子和超分辨率显微成像;以及(5)试点项目计划(PPP)
利用中心资源促进研究工作,并促进与Redox Cobre的合作
会员。我们的目标是成为氧化还原生物学和信号传递的独立中心(简称
“氧化还原中心”),我们将在我们的重大科学和体制成就的基础上再接再厉,以:(目标1)
提升科技核心的功能和效率,实现服务中心的最佳定位
主题性和转化性目标并实现/保持可持续性;(目标2)利用公私伙伴关系发展中心
加入并促进人类背景下翻译氧化还原信号研究的重要性
疾病;(目标3)开发研究组合以及氧化还原Cobre和其他想法之间的联系
将不同学科和专业领域结合在一起的计划,使我们成为一个全国性的存在。
因此,作为一所新兴的大学,我们正在寻求建立一个长期成功的战略地位-
指定的氧化还原中心将是为数不多的国家资源之一,供调查人员利用或开发新的
针对病理性氧化还原途径的技术、治疗和干预。
英文摘要
Overall – Abstract
With Phase III COBRE support, the South Carolina Center in Oxidants, Redox Balance, and Stress Signaling
(Redox COBRE) at the Medical University of South Carolina (MUSC) will complete its transition to long-term
sustainability as a nationally competitive multidisciplinary research program in redox pathobiology. During
Phases I and II, our Redox COBRE was successful in its efforts to (i) expand the critical mass of funded
investigators at MUSC studying the causal role of redox pathways and metabolic dysfunction in a wide range of
human pathologies (cancer, cardiovascular and neurodegenerative diseases, diabetes, gastrointestinal
disorders and drug addiction) and (ii) develop advanced scientific core resources offering a broad range of
capabilities for investigating the biologically significant effects of oxidative stress. Our current core membership
comprises 44 senior and junior faculty members that have received more than $51 million in awards since the
program’s inception. To date, the Redox COBRE has mentored a total of 20 target faculty (junior investigators +
pilot project-supported PIs). Of these individuals, 10 have been promoted and 16 have been retained at our
institution. As a group, these faculty members have published more than 250 peer-reviewed papers and secured
56 extramural grant awards (including 31 NIH grants (PI role) of which 16 are R01 awards and 8 are SBIR/STTR-
supported start-ups). The major components of this Phase III proposal are: (1) an Administrative Core providing
organizational, coordinating, fiscal and accountability functions; (2) an Analytical Redox Core delivering
analytical biochemistry services for quantification of redox-sensitive molecule abundance and redox-based
changes in cellular homeostasis; (3) a Proteomics Core that offers state-of-the-art mass spectrometry (MS) and
MS-imaging capabilities; (4) a Cell & Molecular Redox Imaging Core that provides cell and tissue-based
confocal, multiphoton and super-resolution microscopic imaging; and (5) a Pilot Projects Program (PPP) that
fosters research endeavors utilizing Center resources and facilitates collaborations with Redox COBRE
members. Towards our objective of becoming a stand-alone Center of Redox Biology and Signaling (abbreviated
to “Redox Center”), we will build upon our substantial scientific and institutional achievements, to: (Aim 1)
enhance the function and efficiencies of our scientific cores, achieving optimal positioning to serve Center
thematic and translational goals and achieve/ maintain sustainability; (Aim 2) leverage the PPP to grow center
membership and promote the importance of translational redox signaling research in the context of human
disease; (Aim 3) develop the research portfolio and connections between the Redox COBRE and other IDeA
programs to establish ourselves as a national presence coalescing various disciplines and areas of expertise.
Thus, we are seeking to establish a strategic position for long-term success as an emergent, University-
designated Redox Center that will be one of few national resources for investigators to utilize or develop new
technologies, therapeutics and interventions targeting pathological redox pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10460361
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2021
-
负责人:Kenneth D. Tew
-
依托单位:
South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
-
批准号:10674956
-
项目类别:
-
资助金额:$113.25万
-
财政年份:2021
-
负责人:Kenneth D. Tew
-
依托单位:
South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
-
批准号:10854099
-
项目类别:
-
资助金额:$59.55万
-
财政年份:2021
-
负责人:Kenneth D. Tew
-
依托单位:
Administrative Core
-
批准号:10674958
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2021
-
负责人:Kenneth D. Tew
-
依托单位:
South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
-
批准号:10460360
-
项目类别:
-
资助金额:$113.25万
-
财政年份:2021
-
负责人:Kenneth D. Tew
-
依托单位:
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
-
批准号:8531291
-
项目类别:
-
资助金额:$208.68万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
-
批准号:8359562
-
项目类别:
-
资助金额:$215.29万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
-
批准号:9341341
-
项目类别:
-
资助金额:$224.25万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
Administrative Core
-
批准号:10005393
-
项目类别:
-
资助金额:$122.54万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
-
批准号:8323219
-
项目类别:
-
资助金额:$218.17万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
-
批准号:7826047
-
项目类别:
-
资助金额:$215.29万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
-
批准号:10005385
-
项目类别:
-
资助金额:$224.25万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
-
批准号:8912491
-
项目类别:
-
资助金额:$218.84万
-
财政年份:2011
-
负责人:Kenneth D. Tew
-
依托单位:
PRECLINICAL DEVELOPMENT OF A GLUTATHIONE BASED CANCER DRUG
-
批准号:7221018
-
项目类别:
-
资助金额:$15.02万
-
财政年份:2007
-
负责人:Kenneth D. Tew
-
依托单位:
TRAINING IN CANCER THERAPEUTICS
-
批准号:7652257
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2006
-
负责人:Kenneth D. Tew
-
依托单位:
TRAINING IN CANCER THERAPEUTICS
-
批准号:7067484
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2006
-
负责人:Kenneth D. Tew
-
依托单位:
TRAINING IN CANCER THERAPEUTICS
-
批准号:7455263
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2006
-
负责人:Kenneth D. Tew
-
依托单位:
TRAINING IN CANCER THERAPEUTICS
-
批准号:7884624
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2006
-
负责人:Kenneth D. Tew
-
依托单位:
TRAINING IN CANCER THERAPEUTICS
-
批准号:7254942
-
项目类别:
-
资助金额:$16.39万
-
财政年份:2006
-
负责人:Kenneth D. Tew
-
依托单位:
CORE--CONFOCAL MICROSCOPY
-
批准号:6652209
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:Kenneth D. Tew
-
依托单位:
海外基金